A double-blind randomized controlled trial and economic evaluation of transurethral resection vs contact laser vaporization for benign prostatic enlargement: A 3-year follow-up

BJU International

Volumn 85, Issue 1, 2000, Pages 74-78

  Keoghane, S R ^a   Lawrence, K C ^b   Gray, A M ^c   Doll, H A ^b   Hancock, A M ^a   Turner, K ^a   Sullivan, M E ^a   Dyar, O ^a   Cranston, D ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c WOLFSON COLLEGE   (United Kingdom)

Author keywords

Contact laser prostatectomy; Economics; Randomized controlled trial; Transurethral resection

Indexed keywords

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CATHETERIZATION; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FOLLOW UP; HEALTH ECONOMICS; HUMAN; INTERMETHOD COMPARISON; LASER SURGERY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROSTATECTOMY; RANDOMIZED CONTROLLED TRIAL; REOPERATION; SYMPTOM; TRANSURETHRAL RESECTION; TREATMENT OUTCOME; URINE FLOW RATE; YAG LASER;

AGED; AGED, 80 AND OVER; COSTS AND COST ANALYSIS; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; LASER SURGERY; MALE; MIDDLE AGED; PROSTATIC HYPERPLASIA; TRANSURETHRAL RESECTION OF PROSTATE; TREATMENT OUTCOME;

EID: 1442315430     PISSN: 14644096     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.2000.00407.x     Document Type: Article

References (20)

1. 1 Keoghane SR, Cranston DW. A critical overview on the use of the Nd:YAG laser in the treatment of benign prostatic hypertrophy. Eur Urol 1994; 26: 193-6
2. 2 Anson KM, Nawrocki J. Buckley J et al. A multicenter randomised, prospective study of endoscopic laser ablation versus transurethral resection of the prostate. Urology 1995; 46: 305-10
3. 3 Kablin JN. Laser dosimetry studies in the human prostate. In Marberger M, ed. Applications of Newer Forms of Energy in Urology, Chapt. 14. Oxford: Isis Medical Media, 1995: 143-9
4. 4 Bartsch G, Janetschek G, Watson G, Anson K. The development of an endoscope and of contact probes for transurethral laser surgery of the prostate. J Urol 1994; 151: 333A(Abstract424)
5. 5 de la Rosette JJMCH. Laser ablation of the prostate: coagulation versus vaporisation. In Marberger M, ed, Applications of Newer Forms of Energy in Urology, Chapt. 19. Oxford: Isis Medical Media, 1995: 189-96
6. 6 Costello AJ. Lasers in benign conditions. In Marberger M, ed, Applications of Newer Forms of Energy in Urology, Chapt 21, Oxford: Isis Medical Media, 1995: 205-19
7. 7 Barry MJ, Fowler FJ, O'Leary MP et al. The American Urologic Association symptom index for benign prostatic hyperplasia. J Urol 1992; 148: 1549-57
8. 8 Barry MJ, Fowler FJ, O'Leary MP et al. Correlation of the American Urologic Association symptom index with self administered versions of the Madsen-Iverson, Boyarsky and Maine Medical Assessment Program symptom indexes. J Urol 1992; 148: 1558-63
9. 9 Barry MJ, Chang Y, Walker-Corkery B et al. How much change in the AUA symptom index is perceptible to patients ? J Urol 1995; 153: 319A(Abstract363)
10. 10 Keoghane SR, Lawrence KC, Gray AM, Hancock A, Cranston DW. The Oxford Laser Prostate Trial: Economic issues surrounding contact laser prostatectomy. Br J Urol 1996; 77: 386-91
11. 11 Keoghane SR, Cranston DW, Lawrence KC, Doll HA, Fellows GJ, Smith JC. The Oxford laser prostate trial: a randomised controlled trial of contact vaporisation of the prostate versus TURP - preliminary results. Br J Urol 1996; 77: 382-5
12. 12 McNicholas TA, Hines J. Thermal treatment of the prostate: A review of the options. In Kirby RS, O'Leary MP, eds, Recent Advances in Urology. Edinburgh: Churchill Livingstone, 1998: 103-15
13. 13 McAllister WJ. Absolom MJ. Lawrence W, Patterson P, Watson G, Fowler CG. Does endoscopic laser ablation (ELAP) stand the test of time? 5-year results of a multicentre randomized study of ELAP versus TURP. Rr J Urol 1998; 81 (Suppl 4): 23, Abst58
14. 14 Donovan JL, Brookes ST, Kennedy GL, Abrams P. Peters TJ, Neal DE. The CLasP randomised controlled trial: comparing laser therapy, conservative management and TURP for men with lower urinary tract symptoms. J Urol 1998; 160: 248
15. 15 Pearcy R, Carter A, Sells O'Boyle P, MacDonagh R, Speakman M, Ewings P. Long term follow up of hybrid KTP/Nd:YAG laser treatment of the prostate versus TURP. A prospective randomised trial, 18 month results. J Urol 1999; 161: 390
16. 16 Langley SEM, Gallegos CRR, Moisey CU. A prospective randomised trial evaluating endoscopic Nd:YAG laser prostate ablation with or without potassium titanyl phosphate (KTP) laser bladder neck incision. Br J Urol 1997; 80: 880-4
17. 17 Mackey MJ, Chilton CP, Gilling PJ, Fraundorfer M, Cresswell MD. The results of holmium laser resection of the prostate. Br J Urol 1998; 81: 518-9
18. 18 Tuhkanen K, Heino A, Ala-Opas M. Contact laser prostatectomy compared to TURP in prostatic hyperplasia smaller than 40 ml. Six month follow up with complex urodynamic assessment. Scand J Urol Nephrol 1999; 33: 31-4
19. 19 Sullivan ME, Crew JP, Millar J, Dyar O, Cranston D. Day-case laser prostatectomy: a treatment option for selected patients with bladder outflow obstruction. Br J Urol 1997; 79 (Suppl 4): 29(Abst)
20. 20 Keoghane SR, Millar JM, Cranston DW. Is pure day case laser prostatectomy feasible? Br J Urol 1995; 76: 600-3